HW-252001

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameHW-252001
Drug Alias NameHW252001HW-252001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 4B inhibitors
TargetsPhosphodiesterase 4B
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A